Pharmacielo Ltd - Asset Resilience Ratio

Latest as of December 2023: 0.00%

Pharmacielo Ltd (PCLO) has an Asset Resilience Ratio of 0.00% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Pharmacielo Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CA$0.00

≈ $0.00 USD Cash + Short-term Investments

Total Assets

CA$22.29 Million

≈ $16.12 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2023)

This chart shows how Pharmacielo Ltd's Asset Resilience Ratio has changed over time. See Pharmacielo Ltd (PCLO) net asset quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Pharmacielo Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Pharmacielo Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$0.00	0%
Total Liquid Assets	CA$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Pharmacielo Ltd maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Pharmacielo Ltd Industry Peers by Asset Resilience Ratio

Compare Pharmacielo Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Aurobindo Pharma Limited NSE:AUROPHARMA	Drug Manufacturers - Specialty & Generic	1.28%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Tianjin Chase Sun Pharmaceutical Co Ltd SHE:300026	Drug Manufacturers - Specialty & Generic	-0.89%
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	Drug Manufacturers - Specialty & Generic	0.20%
Xeris Pharmaceuticals Inc NASDAQ:XERS	Drug Manufacturers - Specialty & Generic	0.00%
Procter & Gamble Health Limited NSE:PGHL	Drug Manufacturers - Specialty & Generic	33.01%

Annual Asset Resilience Ratio for Pharmacielo Ltd (2019–2023)

The table below shows the annual Asset Resilience Ratio data for Pharmacielo Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	0.00%	CA$0.00 ≈ $0.00	CA$22.29 Million ≈ $16.12 Million	--
2022-12-31	0.61%	CA$153.00K ≈ $110.68K	CA$25.12 Million ≈ $18.17 Million	-0.20pp
2021-12-31	0.81%	CA$291.00K ≈ $210.50K	CA$35.96 Million ≈ $26.01 Million	-0.89pp
2020-12-31	1.70%	CA$750.05K ≈ $542.57K	CA$44.02 Million ≈ $31.85 Million	+1.49pp
2019-12-31	0.21%	CA$106.00K ≈ $76.68K	CA$50.20 Million ≈ $36.31 Million	--

pp = percentage points

About Pharmacielo Ltd

V:PCLO Canada Drug Manufacturers - Specialty & Generic

Market Cap

$12.24 Million

CA$16.92 Million CAD

Market Cap Rank

#26549 Global

#1093 in Canada

Share Price

CA$0.09

Change (1 day)

-14.29%

52-Week Range

CA$0.04 - CA$0.14

All Time High

CA$11.02